Paul Saladino· MD
The biggest problem with osmpic and mangaro and reatutide for a lot of people is you just don't eat enough. You're essentially having permissive starvation because you feel so full.
Loading…
We can't find evidence that holds up here. Proponents are reasoning from mechanism or analogy rather than direct human data, and the most credible skeptics raise objections we can't dismiss.
The biggest problem with osmpic and mangaro and reatutide for a lot of people is you just don't eat enough. You're essentially having permissive starvation because you feel so full.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
However, the enthusiasm surrounding GLP-1 agonists must be tempered by awareness of possible negative side effects, ranging from lean body mass loss to bone loss.